Physician-pharmacist Collaborative Care for Dyslipidemia Patients: Knowledge and Skills of Community Pharmacists
Overview
Medical Education
Authors
Affiliations
Introduction: In a physician-pharmacist collaborative-care (PPCC) intervention, community pharmacists were responsible for initiating lipid-lowering pharmacotherapy and adjusting the medication dosage. They attended a 1-day interactive workshop supported by a treatment protocol and clinical and communication tools. Afterwards, changes in pharmacists' knowledge, their skills, and their satisfaction with the workshop were evaluated.
Methods: In a descriptive study nested in a clinical trial, pharmacists assigned to the PPCC intervention (n = 58) completed a knowledge questionnaire before and after the workshop. Their theoretical skills were evaluated with the use of a vignette approach (n = 58) after the workshop and their practical skills were assessed by direct observation with study patients (n = 28).
Results: The mean (SD) overall knowledge score was 45.8% (12.1%) before the workshop; it increased significantly to 89.3% (8.3%) afterwards (mean difference: 43.5%; 95% CI: 40.3%-46.7%). All the pharmacists had an overall theoretical-skill score of at least 80%, the minimum required to apply the PPCC in the trial. From 92.9% to 100% of the pharmacists' interventions with study patients complied with the treatment protocol.
Discussion: In primary care, a short continuing-education program based on a specific treatment protocol and clinical tools is necessary and probably sufficient to prepare pharmacists to provide advanced pharmaceutical care.
Zekan L, Mestrovic A, Seselja Perisin A, Bukic J, Leskur D, Rusic D BMJ Open. 2020; 10(6):e034674.
PMID: 32487573 PMC: 7265009. DOI: 10.1136/bmjopen-2019-034674.
Steed L, Sohanpal R, Todd A, Madurasinghe V, Rivas C, Edwards E Cochrane Database Syst Rev. 2019; 12:CD011207.
PMID: 31808563 PMC: 6896091. DOI: 10.1002/14651858.CD011207.pub2.
The impact of pharmaceutical care on patients with hypertension and their pharmacists.
Skowron A, Polak S, Brandys J Pharm Pract (Granada). 2014; 9(2):110-5.
PMID: 24688618 PMC: 3969835. DOI: 10.4321/s1886-36552011000200009.
Lalonde L, Tsuyuki R, Landry E, Taylor J Can Pharm J (Ott). 2013; 145(2):73-76.e1.
PMID: 23509506 PMC: 3567563. DOI: 10.3821/145.2.cpj73.
Villeneuve J, Genest J, Blais L, Vanier M, Lamarre D, Fredette M CMAJ. 2010; 182(5):447-55.
PMID: 20212029 PMC: 2842856. DOI: 10.1503/cmaj.090533.